Zhengye Biotechnology Holding Limited Foreign Currency Cash Flow Hedge Derivative at Fair Value, Net
Zhengye Biotechnology Holding Limited (ZYBT) had Foreign Currency Cash Flow Hedge Derivative at Fair Value, Net of CNY 68.00 thousand as of 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Notes › Derivative Instruments and Hedging Activities
us-gaap:ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet · last filed 2026-04-28
- 2025-12-31: Foreign Currency Cash Flow Hedge Derivative at Fair Value, Net 68.00K CNY.
- 2025-06-30: Foreign Currency Cash Flow Hedge Derivative at Fair Value, Net 838.00K CNY.
- 2024-12-31: Foreign Currency Cash Flow Hedge Derivative at Fair Value, Net 95.00K CNY.
CNY
| Period end | Foreign Currency Cash Flow Hedge Derivative at Fair Value, Net |
|---|---|
| 2025-12-31 | 68.00K CNY 20-F · filed 2026-04-28 |
| 2025-06-30 | 838.00K CNY 6-K · filed 2025-12-12 |
| 2024-12-31 | 95.00K CNY 20-F · filed 2026-04-28 |
USD
| Period end | Foreign Currency Cash Flow Hedge Derivative at Fair Value, Net |
|---|---|
| 2025-12-31 | $10.00 20-F · filed 2026-04-28 |
| 2025-06-30 | $117.00K 6-K · filed 2025-12-12 |